Cellev8 Nutrition Inc.
CELVOTCTechnology● Active
$0.07
$-0.02(-18.75%)
Market Cap$8709043
P/E Ratio—
52W High$0.7
52W Low$0.03
Cellev8 Nutrition Inc.（CELV）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CELV · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-11 | 2024-11 | 2023-11 | 2022-11 | 2021-11 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.42M | $0.17M | $0.11M | $0.03M | $0.02M |
| Net Receivables | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Inventory | $0.02M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $0.44M | $0.28M | $0.18M | $0.04M | $0.02M |
| PP&E Net | $0.00M | $0.00M | $0.00M | $0.01M | $0.01M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $0.45M | $0.44M | $0.34M | $0.20M | $0.17M |
| Liabilities | |||||
| Short-Term Debt | $1.53M | $1.61M | $1.36M | $1.26M | $6.82M |
| Accounts Payable | $0.21M | $0.35M | $1.95M | $1.90M | $1.87M |
| Total Current Liabilities | $1.74M | $1.96M | $3.31M | $3.15M | $8.69M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $1.74M | $1.96M | $3.31M | $3.15M | $8.69M |
| Stockholders Equity | |||||
| Retained Earnings | ($40.23M) | ($39.77M) | ($40.03M) | ($39.31M) | ($38.82M) |
| Total Stockholders Equity | ($1.29M) | ($1.52M) | ($2.97M) | ($2.95M) | ($8.52M) |
| Total Liab & Equity(computed) | $0.45M | $0.44M | $0.34M | $0.20M | $0.17M |
| Debt Summary | |||||
| Total Debt | $1.53M | $1.61M | $1.36M | $1.26M | $6.82M |
| Net Debt | $1.11M | $1.44M | $1.25M | $1.23M | $6.80M |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Cellev8 Nutrition Inc.
关于Cellev8 Nutrition Inc.（CELV）资产负债表
Cellev8 Nutrition Inc.总资产$0.00B，现金及短期投资$0.00B，总负债$0.00B，总债务$0.00B，股东权益($0.00B)。
常见问题
CELV · 4 问Cellev8 Nutrition Inc.总债务$0.00B，净债务$0.00B。
CELV total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10